Organon shareholders approve Sun Pharma's $11.75 billion acquisition, paving the way for it to become a wholly owned subsidiary.

Sun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone moves the proposed transaction closer to completion.…

Organon shareholders approve Sun Pharma's $11.75 billion acquisition, paving the way for it to become a wholly owned subsidiary.